Post Views: 128 The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with NSCLC (non-small cell lung cancer). This approval has been…
Search Results for: chemotherapy
U.S. FDA Approves Lung Cancer Drug, Adagrasib
Post Views: 127 The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated locally advanced or metastatic non-small cell lung cancer in…
Scientists Discover New Gene Target for Aggressive Small Cell Lung Cancer
Post Views: 117 Lung cancer is the leading cause of cancer deaths in the United States. According to the American Cancer Society, an estimated 131,880 lung cancer deaths are predicted for this…
Mesothelioma: Symptoms and Causes
Post Views: 152 Mesothelioma is an aggressive form of cancer that occurs in thin layer of tissue covering the majority of internal organs. It is divided into different types based on what…
Study finds Biomarker in Liquid Biopsy for Lung Cancer Appears Accurate in Predicting Immunotherapy Response
Post Views: 154 The researchers at Mount Sinai have found that a simple blood test called liquid biopsy could be a better indicator of whether cancer immunotherapy will be successful for lung…
All You Need to Know About Pediatric Non-Small Cell Lung Cancer
Post Views: 291 Primary lung cancer is extremely rare in children. Pediatric non-small cell lung cancer (NSCLC) is the term for occurrence of NSCLC in children and adolescents. NSCLC that develops in…
FDA Approves Nivolumab Plus Chemo as Neoadjuvant Therapy for NSCLC Treatment
Post Views: 166 The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab is the first immune checkpoint inhibitor to get approval…
Adenocarcinoma Lung Cancer: Symptoms and Treatment
Post Views: 131 There are two predominant types of lung cancer: small cell lung cancer and non-small cell lung cancer. NSCLC accounts for about 80% to 85% of all lung cancers. Adenocarcinoma…
Lung Cancer Screening in Non-Smoker Women in Taiwan Associated with Overdiagnosis
Post Views: 101 A new study based on data from a National Cancer Registry in Taiwan has found that lung cancer screening may lead to overdiagnosis at the population level. The United…
Sugemalimab with Chemo Demonstrates Improvement in NSCLC Survival Rates
Post Views: 91 In the year 2020, an estimate of 2.2 million people has been diagnosed with lung cancer. It is the second most commonly diagnosed cancer and is among leading cause…
NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer
Post Views: 129 There are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups depending on…
All About Squamous Non Small Cell Lung Cancer
Post Views: 558 The leading cause behind cancer related deaths is lung cancer and most of the lung cancer cases are of non-small cell lung cancer type. NSCLC occurs in about 80%…